News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search


PHARMAC Takes On Board Oral Contraceptive Advice

PHARMAC Takes On Board Advice On Oral Contraceptives

PHARMAC has listened to various submissions, including one from the Family Planning Association, and has dropped plans to tender all oral contraceptives.

Although the proposal would have saved the pharmaceutical budget several million dollars a year, PHARMAC has announced it will not go ahead with it at this time. This is based on the concern that it may confuse women if they have to change brands.

As part of an ongoing initiative by PHARMAC to reduce the price of generic drugs, companies are given the opportunity to tender for certain medicines. The company that wins the tender then has a guaranteed larger market for their sales, and in return can offer a lower price.

This is PHARMAC’s biggest tender round yet, and it had included proposals on a number of oral contraceptives in a bid to get the best possible price for the taxpayer. All proposed tenders are consulted on extensively with the medical profession and drug industry, and concerns were raised in this process.

Based on this just two contraceptives have been left in the tender round. These are Depo-Provera, which is an injection, and Diane-35. Companies will get the opportunity to be the sole supplier of these chemicals by tendering for the lower price. They would still be available, but may have a different brand name with different packaging.

PHARMAC Medical Director Dr Peter Moodie says the decision highlighted the importance of consultation, and showed how PHARMAC is willing to listen.

“This is the exact reason that we go out to the sector and other interested parties to get their views on proposals. They raise valid points and then it is our job to then balance those views in making a final decision on whether it should go ahead or not.”

Dr Moodie says it is also important to stress that any woman who is currently on one of the two brands to remain in the tender process that they will still have receive the same chemical fully funded .

He says savings made from tendering are spent on other health needs and funding of other needed pharmaceuticals.


© Scoop Media

Culture Headlines | Health Headlines | Education Headlines

Gordon Campbell: Best New Music Of 2017

Any ‘best of list’ has to be an exercise in wishful thinking, given the splintering of everyone’s listening habits... But maybe… it could be time for the re-discovery of the lost art of listening to an entire album, all the way through. Just putting that idea out there. More>>

Scoop Review of Books: Ten x Ten - One Hundred of Te Papa's Best-Loved Art Works

An idiosyncratic selection by ten art curators, each of whom have chosen ten of their favourite works. Handsomely illustrated, their choices are accompanied by full-page colour prints and brief descriptions of the work, explaining in straightforward and approachable language why it is of historical, cultural, or personal significance. More>>

Scoop Review of Books: Portacom City - Reporting On Canterbury Earthquakes

In Portacom City Paul Gorman describes his own deeply personal story of working as a journalist during the quakes, while also speaking more broadly about the challenges that confront reporters at times of crisis. More>>

Scoop Review of Books: Christopher Pugsley’s The Camera in the Crowd - Filming in New Zealand Peace and War 1895-1920

Pugsley brings to life 25 exhilarating years of film making and picture screening in a sumptuously illustrated hardback published by Oratia that tells the story through surviving footage unearthed from the national film archives. More>>



  • Wellington
  • Christchurch
  • Auckland